We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00989482
First Posted: October 5, 2009
Last Update Posted: May 16, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of California, San Francisco
  Purpose

The purpose of this study is to improve antibiotic prescribing practices of Mexican primary care physicians for patients seeking care for acute respiratory tract infections (ARIs). The investigators will employ a combination of qualitative and quantitative methods to develop and evaluate a patient education and physician decision-support intervention.

Hypothesis 1: The investigators will identify barriers and facilitators of appropriate antibiotic use for ARIs that can be addressed through patient education and physician decision-support.

Hypothesis 2: The proportion of patients who report desire for antibiotics as a "very important" reason for seeking care will decrease from 50% to 30% following exposure to the educational intervention; and 90% (95% confidence interval: 80% to 100%) of patients will report that they trust the information provided by the computer.

Hypothesis 3: Antibiotic prescribing for adults with uncomplicated acute bronchitis will decrease from 80 percent to 40 percent following the introduction of a real-time clinical decision support tool.


Condition Intervention
Acute Respiratory Tract Infections Behavioral: Computer kiosk Education

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Official Title: Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • antibiotic prescription rate [ Time Frame: 4 months ]

Enrollment: 847
Study Start Date: January 2010
Study Completion Date: September 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Computer Kiosk Eduction Behavioral: Computer kiosk Education
computerized patient education; guidelines for physicians

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adults age 18 years or greater

Exclusion Criteria:

  • mental disability; severe illness
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00989482


Locations
Mexico
IMSS Family Practice Clinic #1
Cuernavaca, Morelos, Mexico
Sponsors and Collaborators
University of California, San Francisco
  More Information

Responsible Party: Ralph Gonzales, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00989482     History of Changes
Other Study ID Numbers: Fulbright-Gonzales
First Submitted: July 24, 2009
First Posted: October 5, 2009
Last Update Posted: May 16, 2011
Last Verified: May 2011

Additional relevant MeSH terms:
Respiratory Tract Infections
Infection
Respiratory Tract Diseases
Anti-Bacterial Agents
Anti-Infective Agents